In this paper we discuss the value of N-of-1 trials in personalising health care. We describe the challenges faced in implementing N-of-1 trials in the United Kingdom's National Health Service and suggest how making greater use of these personalised trials might be facilitated.
Keywords: N-of-1; barriers; hyper-regulation of clinical research; implementation; methods; personalised healthcare; trials.